comparemela.com

Martinaa Sersch News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Gracell Biotechnologies to Present Updated Clinical Data on BCMA/CD19 Dual-Targeting CAR-T GC012F for Relapsed/Refractory Multiple Myeloma at 2022 ASCO Annual Meeting

/PRNewswire/ Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to.

United statesMartinaa serschMarvin tangKyle evansExchange commissionGracell biotechnologies incAmerican society of clinical oncologyDrug administrationEuropean hematology associationGracell biotechnologiesClinical oncologyOrphan drug designationChief medical officerHematologic malignanciesPlasma cellPrivate securities litigation reform act

Gracell Biotechnologies to Present Updated Clinical Data on BCMA/CD19 Dual-Targeting CAR-T GC012F for Relapsed/Refractory Multiple Myeloma at 2022 ASCO Annual Meeting

/PRNewswire/ Gracell Biotechnologies Inc. ("Gracell" or the "Company", NASDAQ: GRCL), a global clinical-stage biopharmaceutical company dedicated to.

United statesMartinaa serschMarvin tangKyle evansExchange commissionGracell biotechnologies incAmerican society of clinical oncologyDrug administrationEuropean hematology associationGracell biotechnologiesClinical oncologyOrphan drug designationChief medical officerHematologic malignanciesPlasma cellPrivate securities litigation reform act

Gracell Biotechnologies Announces Senior Management Team Share Purchase Plan

/PRNewswire/ Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell" or the "Company"), a global clinical-stage biopharmaceutical company dedicated to.

United statesMartinaa serschMarvin tangWilliam wei caoYili kevin xieExchange commissionPrnewswire gracell biotechnologies incCompany americanGracell biotechnologies incChief executive officerChief financial officerChief medical officerPrivate securities litigation reform actGracell biotechnologies inc

Gracell Biotechnologies Announces Senior Management Team Share Purchase Plan

/PRNewswire/ Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell" or the "Company"), a global clinical-stage biopharmaceutical company dedicated to.

United statesMartinaa serschMarvin tangWilliam wei caoYili kevin xieExchange commissionPrnewswire gracell biotechnologies incCompany americanGracell biotechnologies incChief executive officerChief financial officerChief medical officerPrivate securities litigation reform actGracell biotechnologies inc

vimarsana © 2020. All Rights Reserved.